BMO Capital Markets analysts expect a slow launch, however, writing in a note to investors about challenges including a black box warning for risk of acute adrenal insufficiency or adrenal crisis with inadequate concomitant glucocorticoid therapy. The firm said it anticipates broad commercial access will not happen until the second half of 2025
The presence of folate receptor- autoantibodies represents a biologically defined ASD endophenotype with higher responsiveness to folinic acid, illustrating the value of biomarker-guided intervention
Nicholas AK, Uzoamaka N, Mary A, Christy O, Joseph AI (2021) Spirulina consumption: concerns regarding contaminants and uncommon but possible adverse reactions and interactions
By combining medical expertise with a broader understanding of wellness, Christine Collins, MD helps patients feel more supported , more aligned , and better equipped to maintain long-term health